East Hills, NY (January 25, 2005) - - Pall Corporation (NYSE:PLL) today announced that is has acquired Euroflow (UK) of Stroud, England. The company is one of the world's leading manufacturers of pilot and production scale chromatography columns for the biotechnology industry. Pall held exclusive global marketing and distribution rights to Euroflow chromatography columns and associated technologies since 2002. Euroflow sales are currently about $5 million a year.
Pall also recently broadened its position in the chromatography market with its November 2004 acquisition of the BioSepra Process Division from Ciphergen Biosystems, Inc. Pall BioSepra develops, manufacturers and markets chromatography sorbents that greatly simplify protein purification for drug development and production. Both acquisitions target the rapidly growing biotechnology industry and allow Pall to provide a more complete "Total Fluid Management" systems approach to customers. The chromatography market represents about 40% of the total biotech industry potential for filtration and purification technologies.
Eric Krasnoff, Chairman and CEO of Pall Corporation, said, "We welcome Euroflow to our growing family of purification technologies. We are responding to the industry's request for integrated systems solutions for purification technologies from development through large-scale production. Pall's Total Fluid Management approach helps customers to consistently meet productivity, quality and regulatory requirements at the lowest cost of ownership."
About Pall Corporation Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification. Pall's business is organized around two broad markets: Life Sciences and Industrial. The Company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceuticals, transfusion medicine, semiconductors, water purification, aerospace and broad industrial markets. Total revenues are $1.8 billion. The Company headquarters are in East Hills, New York with extensive operations throughout the world. Visit Pall at http://www.pall.com/.
This release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current Company expectations and are subject to risk and uncertainties, which could cause actual results to differ materially. Such risks and uncertainties include, but are not limited to: fluctuations in foreign currency exchange rates; regulatory approval and market acceptance of new technologies; changes in product mix and product pricing and in interest rates and cost of raw materials; the Company's success in enforcing its patents and protecting its proprietary products and manufacturing techniques and its ability to achieve the savings anticipated from its cost reduction initiatives; global and regional economic conditions and legislative, regulatory and political developments; and domestic and international competition in the Company's global markets. Additional information regarding these and other factors is available on the Web at www.pall.com and is included in the Company's reports filed with the U.S. Securities and Exchange Commission. Copies of such reports can be obtained, without charge, at www.sec.gov.